Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/12/2003CN1454658A Tinea-wiping and pox-removing skin-nursing lotion
11/12/2003CN1454656A Medicine for curing leuconychia and hand-foot ringworm and preparing method thereof
11/12/2003CN1454639A Skin-haemorrhoids-clearing ointment and preparing method thereof
11/12/2003CN1454633A External-use Chinese medicine composition for curing virus influenza
11/12/2003CN1454606A Heat-clearing and detoxicating medicine for common cold
11/12/2003CN1454604A Medicine for curing hydrophobia during morbidity
11/12/2003CN1454603A Chinese medicine composition for curing hepatitis B and hepatitis B concurrent mental idness
11/12/2003CN1454593A Use of total bryostatin for preparing medicine for anti SARS coronavirus
11/12/2003CN1454592A Medical use of andrographolide and its derivatives
11/12/2003CN1454484A Antivirus, wind-dispelling and dampness-removing, and sterilizing disinfectant for Yao nationality medicine and its preparation process
11/12/2003CN1127515C Process for preparing certain AzA
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127508C Polyene antibiotics 3874 H1-H6, preparation method and use thereof
11/12/2003CN1127494C Neuaminic acid dervatives, their preparation and their medical use
11/12/2003CN1127345C Process for preparing liquid medicine to care verrucosis and gonorrhea
11/12/2003CN1127341C Medicine for treating dysentery
11/12/2003CN1127338C Anti-vaginitis composition for topiical use comprising one or move anti-vaginitis medicaments and one or more local anaesthetics
11/12/2003CN1127337C Method of treating or preventing non-viral microbial infection
11/12/2003CN1127335C AIDS resisting medicine and its use thereof
11/11/2003US6647358 Pharmacokinetic-based drug design tool and method
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646143 Anticancer agents; skin disorders
11/11/2003US6646108 Process for isolating IgG and IgA
11/11/2003US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645986 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
11/11/2003US6645981 Antimicrobial quinolones, their compositions and uses
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645960 Antifungal sordaricin derivatives
11/11/2003US6645956 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment
11/11/2003US6645941 Bactericides, antiprotozoa agents
11/11/2003US6645940 Oligosaccharide derivatives and process for producing the same
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645518 Uses for medical devices having a lubricious, nitric oxide-releasing coating
11/11/2003US6645506 Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003US6644320 Treatment of hepatitis C using hyperthermia
11/11/2003CA2340070C Non-virulent porphyromonas gingivalis mutant
11/11/2003CA2264745C Method of inhibiting biosynthesis of eif5a
11/11/2003CA2259594C Subunit respiratory syncytial virus vaccine preparation
11/11/2003CA2210294C Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
11/06/2003WO2003091437A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003WO2003091429A1 Antimicrobial polypeptide and utizliation thereof
11/06/2003WO2003091401A2 Multi plasmid system for the production of influenza virus
11/06/2003WO2003091290A1 Method for reduction of residual organic solvent in carbomer
11/06/2003WO2003091275A2 Compositions containing anti-hiv peptides and methods of use
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091245A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism
11/06/2003WO2003091241A1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists
11/06/2003WO2003091237A1 Process for producing proanthocyanidine-rich material
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
11/06/2003WO2003091212A1 Cinnamic acid amides
11/06/2003WO2003090774A1 Mannose binding lectin and uses thereof
11/06/2003WO2003090770A1 Process for producing proanthocyanidine-rich material
11/06/2003WO2003090762A1 Long acting compositions comprising zidovudine and lamivudine
11/06/2003WO2003090760A1 Oxolide antibacterials
11/06/2003WO2003090752A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003090751A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003WO2003090748A1 Use of compounds having ccr antagonism
11/06/2003WO2003090744A1 Antibacterial compositions comprising metal phthalocyanine analogues
11/06/2003WO2003090740A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori
11/06/2003WO2003090739A1 Use of conjugated linoleic acid derivatives
11/06/2003WO2003090726A2 Chewable soft capsule
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090687A2 Using heat shock proteins to increase immune response
11/06/2003WO2003090679A2 11-deoxy azalide antibacterials
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2003090667A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003WO2003090665A2 Regulation of erythrocyte apoptosis
11/06/2003WO2003080112A3 Imidazoquinolineamines as adjuvants in hiv dna vaccination
11/06/2003WO2003079981A3 Bioadhesive drug delivery system
11/06/2003WO2003075685A3 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
11/06/2003WO2003070171A3 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
11/06/2003WO2003059193A3 Use of nanoparticles as carriers for biocides in ophthalmic compositions
11/06/2003WO2003057166A3 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003WO2003054009A3 Apoptotically active peptides
11/06/2003WO2003049766A3 Method of purifying hepatitis a virus particles and vaccine preparation
11/06/2003WO2003049688A3 Bis hydrochloride monohydrate salt of rsv fusion inhibitor
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003WO2003035004A3 Immunotherapy for reversing immune suppression
11/06/2003WO2003032985A3 Concomitant oral and topical administration of anti - infective agents
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003030934A3 Cpg formulations and related methods
11/06/2003WO2003030615A3 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones
11/06/2003WO2003030613A3 Methods of treating liver fibrosis and hepatitis c virus infection
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003026589A3 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
11/06/2003WO2003023021A3 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
11/06/2003WO2003018745A3 Method of screening for drug hypersensitivity reaction
11/06/2003WO2003018049A3 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
11/06/2003WO2003015714A3 Compositions and therapeutic methods for viral infection
11/06/2003WO2003013428A3 Nutritional supplements and methods of using same
1 ... 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 ... 1798